Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « increase »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
incorporation < increase < increased  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000024 (2020) Joel Hirsh ; Patrick Wood ; Angela Keniston ; Dennis Boyle ; Itziar Quinzanos ; Liron Caplan ; Lisa DavisUniversal Health Literacy Precautions Are Associated With a Significant Increase in Medication Adherence in Vulnerable Rheumatology Patients
000055 (2020) Pan Luo [République populaire de Chine] ; Yi Liu [République populaire de Chine] ; Lin Qiu [République populaire de Chine] ; Xiulan Liu [République populaire de Chine] ; Dong Liu [République populaire de Chine] ; Juan Li [République populaire de Chine]Tocilizumab treatment in COVID-19: A single center experience.
000070 (2020) Yasmine F. Ibrahim [Égypte] ; Rabab A. Moussa [Égypte] ; Asmaa M A. Bayoumi [Égypte] ; Al-Shaimaa F. Ahmed [Égypte]Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-κB/JNK: a possible role of P-glycoprotein.
000101 (2020) Mohammed Shah ; Derek M. Yellon ; Sean M. DavidsonThe Role of Extracellular DNA and Histones in Ischaemia-Reperfusion Injury of the Myocardium
000103 (2020) Champa N. Ratnatunga [Australie] ; Viviana P. Lutzky [Australie] ; Andreas Kupz [Australie] ; Denise L. Doolan [Australie] ; David W. Reid [Australie] ; Matthew Field [Australie] ; Scott C. Bell [Australie] ; Rachel M. Thomson [Australie] ; John J. Miles [Australie]The Rise of Non-Tuberculosis Mycobacterial Lung Disease
000109 (2020) Eric Toussirot [France]The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition
000177 (2020) Kaveh Hajifathalian ; Srihari Mahadev ; Robert E. Schwartz ; Shawn Shah ; Kartik Sampath ; Felice Schnoll-Sussman ; Robert S. Brown Jr ; David Carr-Locke ; David E. Cohen ; Reem Z. SharaihaSARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant
000183 (2020) Ibai Los-Arcos [Espagne] ; Juan Aguilar-Company [Espagne] ; Isabel Ruiz-Camps [Espagne]Risk of infection associated with new therapies for lymphoproliferative syndromes.
000187 (2020) Durga Prasanna Misra [Inde] ; Vikas Agarwal [Inde] ; Armen Yuri Gasparyan ; Olena Zimba [Ukraine]Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
000241 (2020) Nick Bansback ; Jeffrey R. Curtis ; Jie Huang ; Zeling He ; Michael Evans ; Tracy Johansson ; Kaleb Michaud ; Gabriela Schmajuk ; Katherine P. LiaoPatterns of Tumor Necrosis Factor Inhibitor (TNFi) Biosimilar Use Across United States Rheumatology Practices
000282 (2020) Panyang Xu [République populaire de Chine] ; Qi Zhou [République populaire de Chine] ; Jiancheng Xu [République populaire de Chine]Mechanism of thrombocytopenia in COVID-19 patients
000284 (2020) Prativa Sahoo [États-Unis] ; Xin Yang [États-Unis] ; Daniel Abler [États-Unis] ; Davide Maestrini [États-Unis] ; Vikram Adhikarla [États-Unis] ; David Frankhouser [États-Unis] ; Heyrim Cho [États-Unis] ; Vanessa Machuca [États-Unis] ; Dongrui Wang [États-Unis] ; Michael Barish [États-Unis] ; Margarita Gutova [États-Unis] ; Sergio Branciamore [États-Unis] ; Christine E. Brown [États-Unis] ; Russell C. Rockne [États-Unis]Mathematical deconvolution of CAR T-cell proliferation and exhaustion from real-time killing assay data
000375 (2020) Helga Ellingsgaard [Danemark] ; Eleonora Seelig [Suisse] ; Katharina Timper [Suisse] ; Michael Coslovsky [Suisse] ; Line Soederlund [Danemark] ; Mark P. Lyngbaek [Danemark] ; Nicolai J. Wewer Albrechtsen [Danemark] ; Arno Schmidt-Trucks Ss [Suisse] ; Henner Hanssen [Suisse] ; Walter O. Frey [Suisse] ; Kristian Karstoft [Danemark] ; Bente K. Pedersen [Danemark] ; Marianne Böni-Schnetzler [Suisse] ; Marc Y. Donath [Suisse]GLP-1 secretion is regulated by IL-6 signalling: a randomised, placebo-controlled study.
000386 (2020) Matthew Mankarious [Royaume-Uni] ; Nick C. Matthews [Royaume-Uni] ; John A. Snowden [Royaume-Uni] ; Arun Alfred [Royaume-Uni]Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD)
000394 (2020) Alberto Meneguzzo ; Annalisa Lazzarotto ; Mauro AlaibacEruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal Cancer
000462 (2020) Renate U. Wahl ; Marike Leijs [Belgique] ; Arturo Araujo [Royaume-Uni] ; Albert RübbenCorrelative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma—An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor Therapy of Cancer
000467 (2020) Coronavirus Infection Among Children and Adolescents
000505 (2020) Giulia Lanzolla [Italie] ; Guia Vannucchi [Italie] ; Ilaria Ionni [Italie] ; Irene Campi [Italie] ; Federica Sileo [Italie] ; Elisa Lazzaroni [Italie] ; Michele Marin [Italie]Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy
000552 (2020) Tomasz J. Guzik [Royaume-Uni] ; Saidi A. Mohiddin [Royaume-Uni] ; Anthony Dimarco [Royaume-Uni] ; Vimal Patel [Royaume-Uni] ; Kostas Savvatis [Royaume-Uni] ; Federica M. Marelli-Berg [Royaume-Uni] ; Meena S. Madhur [États-Unis] ; Maciej Tomaszewski [Royaume-Uni] ; Pasquale Maffia [Royaume-Uni] ; Fulvio D'Acquisto [Royaume-Uni] ; Stuart A. Nicklin [Royaume-Uni] ; Ali J. Marian [États-Unis] ; Ryszard Nosalski [Royaume-Uni] ; Eleanor C. Murray [Royaume-Uni] ; Bartlomiej Guzik [Pologne] ; Colin Berry [Royaume-Uni] ; Rhian M. Touyz [Royaume-Uni] ; Reinhold Kreutz [Allemagne] ; Dao Wen Wang [République populaire de Chine] ; David Bhella [Royaume-Uni] ; Orlando Sagliocco [Italie] ; Filippo Crea [Italie] ; Emma C. Thomson [Royaume-Uni] ; Iain B. Mcinnes [Royaume-Uni]COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.
000571 (2020) Seong-Kyu Kim ; Sang Gyu Kwak [Corée du Sud] ; Jung-Yoon ChoeAssociation between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry.
000578 (2020) Marco Cavaco ; Diana Gaspar ; Miguel Arb Castanho ; Vera NevesAntibodies for the Treatment of Brain Metastases, a Dream or a Reality?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "increase" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "increase" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    increase
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021